Biotech and Pharmaceuticals

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…

Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…

Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…

Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it…

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…

Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…

Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart…

Novo Nordisk shareholders are suing the drugmaker over its experimental obesity treatment CagriSema, alleging the company misled investors…

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters Novo Nordisk said on…

The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…

Lilly is ramping up future manufacturing for Foundayo obesity pill